Ectal PowerPoint PPT Presentations

"Welcome to Janvi Multispeciality Hospital. A friendly neighbourhood you can access whenever you have any emergency. As a best Multispeciality hospital in Vadodara, we are striving to become your one-stop, multi-disciplinary healthcare centre, who offers you exclusive medical services. In combination with our courteous staff and state-of-the-art facilities, we pride ourselves on having well-trained and highly skilled doctors. We provide and exchange detailed information with our patients and their families to coordinate the decisions accordingly. We know the importance of a patient-doctor relationship and always maintain utmost privacy and respect for our patients. Maintaining patient’s health, building trust and providing the highest quality medical service and treatment to our patients is our priority. For more info. visit our site:- https://www.janvihospital.com/"

Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Colorectal Cancer. Browse full report @ http://bit.ly/1aJpHP4

Pelviano: Relacionado con la pelvis. P lvico: Situado en o cerca de la pelvis. Caudal: Constitutivo, perteneciente o relativo a la cola. Simetr a bilateral ...

none

Solar Magnetism

Big Market Research, Global Pharma Point Colorectal Cancer Drug Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems. By 2023, the end of the forecast period, GlobalData projects CRC sales to rise to $8.11 billion in the 8MM, at a moderate Compound Annual Growth Rate (CAGR) of 4.9%. Major drivers of the growth of the CRC market over the forecast period include increasing CRC incident cases, the launch of premium-priced adjuvant and maintenance treatments for first-line metastatic disease, and the launch of pipeline agents for later-line CRC. Annualized Colorectal cancer therapeutics market revenue, annual cost of therapy, and treatment usage patterns in eight patient segments, forecast from 2013 to 2023.